. In the nucleus, sialic acid is activated to CMP-sialic acid and delivered into the Golgi lumen by the action of the CST 8, 9 ( Fig. 1a) . CSTs belong to the solute carrier SLC35 family of nucleotide sugar transporters (NSTs), which in humans translocate seven other essential sugars into the ER and/or Golgi for glycosylation in the form of GDPfucose, UDP-galactose, UDP-glucose, UDP-xylose, UDP-GlcNAc, UDP-GalNAc and UDP-GlcA 8, 10 . SLC35 activities are important to human physiology and have been associated with diseases such as obesity 11, 12 . SLC35 members can influence the efficacy of anti-cancer drugs 13 and transport UDP-glucuronic acid into liver cell ER for glucuronidation 14 , which is an essential process for the metabolism of many drugs, such as analgesics, nonsteroidal anti-inflammatory agents, antipsychotics, antivirals and benzodiazepines 15 . A number of NSTs show overlapping substrate specificities 8, 16 , transporting the charged nucleotide-diphosphate sugar (GDP or UDP sugar) in exchange for their counter nucleotide monophosphate (GDP or UMP). CSTs are atypical nucleotide-sugar transporters, as they are only localized to Golgi organelles and transport sialic acid conjugated to a nucleotide monophosphate; they catalyze the exchange of cytoplasmic CMP-sialic acid for Golgi luminal CMP 8, 9, 17 . Several CST mutations have been linked to human pathologies 18 and congenital glycosylation disorders 19 . Because sialyation efficiency affects the therapeutic efficacy of many therapeutic glycoproteins 20, 21 , CST is also a promising candidate for glycoengineering, as it is the rate-limiting factor in the sialyation of glycoproteins 22 . Recently, an outward-facing structure of a nucleotide-sugar transporter for the yeast GDP-mannose transporter Vrg4 was reported 23 . However, as GDP-mannose is not used in higher eukaryotic organisms 24 and because of the large evolutionary gap between GDP-mannose and CMP-sialic acid transporters 25 , the molecular basis for how activated sialic acid is transported into Golgi is still yet to be established.
Results
Crystal structures of the human CMP-sialic acid transporter homolog CST ZM . The CST homolog from Z. mays (CST ZM ) with ~28% sequence identity to human CST (hCST) and ~80-92% sequence identity to Arabidopsis thaliana and Oryza sativa CST proteins, shown to transport CMP-sialic acid and complement the CST deficiency of the Chinese hamster ovary mutant cell line Lec2 (refs. 26, 27 ), was identified using fluorescent-based screening methods 28, 29 as a suitable candidate for structural studies ( Supplementary Fig. 1 ). Binding analysis using the GFP-thermal shift (GFP-TS) assay showed that CST ZM was significantly thermostabilized by CMP, but not by the other nucleotide monophosphates analyzed 30 . CMP binding affinities (K d ) of CST ZM and hCST were further measured and shown be similar to each other and were consistent with results from isothermal titration calorimetry analysis 30 . We confirmed significantly enhanced transport of [ 3 H]CMP when CST ZM proteoliposomes were preloaded with CMP-sialic acid as compared to either unloaded liposomes or those preloaded with a different nucleotide sugar (Fig. 1b) . The [ 3 H]CMP/CMP-sialic acid exchange activity of CST ZM was comparable to that measured in parallel for hCST, and further kinetic analysis showed that the apparent Michaelis constant K M values at 4-8 μM were similar to one another and to that reported previously 8, 17, 31 ( Fig. 1b and Supplementary Fig. 1b ). Thus, we concluded that CST ZM is a suitable model system to establish the molecular basis for CMP-sialic acid transport into Golgi.
CST ZM was crystallized by vapor diffusion and in meso (lipidic cubic phase (LCP)) methods in the absence and presence of CMP, respectively (Methods). The CST ZM crystal structures were solved using molecular replacement and refined against data to 3.4 Å and 2.8 Å for vapor diffusion and LCP crystals, respectively ( Supplementary Fig. 2 , Table 1 , and Methods). Both CST ZM structures were captured in an outward-facing conformation, which in a cellular context places the cavity opening to the Golgi lumen for the binding of CMP (Fig. 1a,c) . A comparison of CST ZM with the outward-facing structure of the GDP-mannose yeast transporter Vrg4 showed a surprisingly large degree of structural difference, with an r.m.s. deviation of 4.9 Å for 179 pairs of Cα atoms (Methods and Supplementary Fig. 2b ). Poor superimposition was also observed between the apo CST ZM and Vrg4 structures ( Supplementary  Fig. 2c ), which means that the structural differences observed were unlikely to have been substrate induced, consistent with the almost identical superimposition between the apo and CMP-bound CST ZM structures (Methods and Supplementary Fig. 2d ). Extensive repositioning of transmembrane helices (TMs) TM3, TM6 and TM8 reshapes the outward-facing state to give unique cavities for CST ZM and Vrg4 ( Fig. 1e and Supplementary Fig. 2b) . Interestingly, the structural divergence between CST ZM and Vrg4 proteins are as extensive as the structural differences between CST ZM and the ]CMP by CST ZM (black squares) and hCST (red circles) is significantly higher in CST ZM proteoliposomes preloaded with CMP-sialic acid compared with that of GDP-mannose (green circles) or buffer only (brown circles). The proteoliposome setup is shown as a schematic in the upper left-hand corner. Errors bars, s.e.m.; n = 3 independent experiments. c, Slab through the CST ZM , with solvent-exposed surface (colored according to the calculated electrostatic potential, presented in blue-positive to red-negative) as viewed within the plane of membrane with CMP (shown as yellow sticks) and the proposed site for sialic acid binding (indicated by an ellipse). d, Ribbon representation of the outward-facing CST ZM , viewed from the top (TMs are numbered and shown as cartoons, colored as a rainbow from blue to red; CMP shown as yellow sticks). The loop residues 27-30, which could not be built, are indicated by a dotted line. e, Slab through the surface of outward-facing CST ZM (left; light brown) and outward-facing Vrg4 (PDB ID 5OGK, right, gray), as viewed from the top, which highlights the difference in binding position of the substrate's CMP (left; green sticks) and GDP-mannose (right; purple sticks) relative to the cavity. unrelated amino acid transporter YddG 32 , a structural homolog used for phasing CST ZM (Methods and Supplementary Fig. 2e ).
Owing to the destabilization of CST ZM by monoolein, LCP crystals could only be obtained in the presence of 1.2 mM CMP, which significantly stabilized the protein 30 . An omit map showed strong positive density for CMP, which was absent in the apo CST ZM structure obtained with vapor-diffusion crystals ( Supplementary  Fig. 2b ). Unexpectedly, CMP binds at the peripheral end of the large cavity, between TM2, TM3 and TM7 (Fig. 1c-e) . The binding site for CMP shares no overlap with the position of GDP in the GDPmannose-bound structure of Vrg4, where the substrate binds more centrally and is coordinated by residues from TM1, TM7, TM8 and TM9 ( Fig. 1e and Supplementary Fig. 2b) . Rather, the repositioning of TMs in CST ZM creates a pocket that is not observed in Vrg4 but is highly complementary to the structure of CMP ( Fig. 1e and Supplementary Fig. 2b ). Reflecting their poor overall structural superimposition, the side chain chemistry between the two proteins is highly divergent at the respective GDP-mannose and CMP binding sites (Supplementary Fig. 3 ). Despite these differences, most residues surrounding CMP within the CST subfamily are highly conserved ( Supplementary Fig. 3c ).
Molecular recognition of CMP and CMP-sialic acid by CST ZM and human CST. Using the GFP-TS assay, we found that the addition of CMP increased the melting temperature (Τ m ) of CST ZM by ~7.8 °C, compared to only ~1 °C for UMP or sialic acid, and was thus used to measure substrate binding of wild-type and mutant CST ( Supplementary Fig. 1c-f and Supplementary Table 1 ). In the CST ZM structure, the nucleobase cytosine forms π-stacking interactions with Trp209 and hydrogen bonds to the carbonyl group of Asn86 (Fig. 2a) . The ribose moiety is coordinated by hydrogen bonds to Ser79 and by van der Waals interactions to Leu83 and Phe205. The phosphate group is coordinated to the side chains of Glu42 and Try82 via highly ordered water molecules. With the exception of Ser79, single-alanine mutants of these residues strongly reduced CMP binding ( Fig. 2b and Supplementary Fig. 4a ). The alanine mutants that completely abolished CMP binding were Tyr82, Asn86, and Trp209. Apart from Trp209, all these residues are strictly conserved in related SLC35 members but not conserved in Vrg4 at the sequence or the structural level ( Supplementary  Fig. 3a,b and Supplementary Note). In support of their relevance to CST proteins, single-alanine substitutions at equivalent positions in hCST also abolished CMP binding (Fig. 2c) . Interestingly, the serine equivalent to Ser79 in hCST (Ser95) also showed enhanced CMP binding when substituted to alanine, and binding assays further confirmed that it increased the apparent affinity (K d ) of CST ZM and hCST proteins for CMP ~10-fold ( Fig. 2c and Supplementary  Fig. 4b,c) . Thus, polar interactions with ribose do not appear to be critical for CMP binding; rather, CMP recognition appears to be primarily established through coordination of the phosphate and cytosine moieties.
In a surface representation of CST ZM , the phosphate moiety points toward a large patch of positively charged electrostatic potential, which is a highly favorable interaction surface for the negatively charged sialic acid sugar (Fig. 1c) . In addition to the waters interacting directly with the phosphate moiety, there is also a network of well-coordinated waters that extends from one end of the 23-Å cavity to the other ( Fig. 2a and Supplementary Fig. 3d ). Noticeably, crystallographic waters at the opposite end of the cavity interact with well-conserved lysine residues Lys108 and Lys262 ( Fig. 2a and Supplementary Note). Remarkably, Lys108 and Lys262 alanine substitutions abolished CMP binding in CST ZM (Fig. 2b) . In hCST, the equivalent lysine to Lys262, Lys272, abolished CMP binding when substituted to alanine, and the equivalent lysine to Lys108, Lys124, showed reduced binding (Fig. 2c) . In comparison, alanine substitutions of the polar residues Asn106 and Ser267, located near these residues but not interacting with these waters, retained robust CMP binding ( Supplementary Fig. 4a ). CMP is further connected to the bottom of the cavity through water-mediated contacts to conserved residues Lys45 (Lys55 in hCST) and Tyr199 (Tyr214 in hCST), which were likewise found to be essential for binding ( Fig. 2b and Supplementary Note). Thus, the binding of CMP is additionally coordinated by an intricate hydrogen-bonding network of waters and charged groups.
One would expect the binding site for CMP to be unaltered when CMP is conjugated to sialic acid. To confirm this assumption, single-alanine mutants assessed for CMP binding were remeasured with CMP-sialic acid. CMP and CMP-sialic acid binding profiles in both hCST and CST ZM proteins were almost identical ( Fig. 2b-e) . Most notably, alanine substitutions of Glu42 and Ser79 residues that retained CMP binding in CST ZM also retained CMP-sialic acid binding. Likewise, Ser95 and Lys124 residues that retained CMP binding in hCST also retained CMP-sialic acid binding. All remaining alanine mutations shown to abolish CMP binding also abolished CMP-sialic acid binding ( Fig. 2b-e) . These data strongly suggest that CMP binds to the same position regardless of its coupling to sialic acid. As such, the highly coordinated waters next to the phosphate moiety should therefore represent the location of the sialic acid binding site (Fig. 2a) . Consistent with this line of reasoning, in the related phosphate-bound structure of the triose-phosphate transporter TPT, a water network located next to phosphate was, indeed, replaced by glycerate in the phospho-glycerate-bound structure 33 . Modeled in this position, sialic acid would be suitably located to interact with the positively charged surface formed by the lysine residues Lys45 (TM2), Lys108 (TM4) and Lys262 (TM9) ( Supplementary Fig. 5 ).
Vrg4 and the related TPT structure harbor a lysine residue in the same position as Lys108 (TM4) in CST ZM ( Supplementary Fig. 5c -e). . The CMP is shown as green sticks, waters are in light brown spheres, and residues coordinating CMP and waters are shown as sticks (colored as in Fig. 1d ). Dashed lines represent hydrogen bond distances at ~2.7−3.5 Å, except the longer K262 to water distance of 4.3 Å; water positions are conserved between the two molecules in the asymmetric unit within 1.7 Å. The π-cation interaction between W209 and cytosine nucleobase is also shown. Single-alanine mutants of hCST residues equivalent to Y199 (Y214 (refs. 55, 56 )), and K262 (K272 (ref. In Vrg4, the TM4-embedded lysine does not directly coordinate GDP-mannose, whereas in TPT, it does 23, 33 ( Supplementary  Fig. 5c,d ). However, because Lys108 is located far from the terminal phosphate in CST ZM , and given that the equivalent lysineto-alanine mutation (of Lys124) did not abolish CMP-sialic acid binding in hCST, we predict that it does not directly coordinate sialic acid (Supplementary Fig. 5a ). In contrast, Lys262, located on TM9, was critical for CMP and CMP-sialic acid binding in both CST ZM and hCST proteins and is positioned closer to the terminal phosphate. Furthermore, in the Vrg4 and TPT structures, a TM9-embedded lysine was likewise shown to make direct hydrogen bond interactions to the respective substrates 23, 33 ( Supplementary  Fig. 5c,d) . Thus, we think that Lys262, together with the essential Lys45 (Fig. 2b-e) , probably directly coordinates sialic acid in CST ( Supplementary Fig. 5a ). Notably, consistent with the lack of apparent overlap in the sugar binding sites between sialic acid in CST and mannose in Vrg4, the TM9-embedded lysine seems to adjust its position along this helix ( Supplementary Fig. 5c-e) .
Even though the K124A mutation in hCST had retained some substrate-binding ability, exchange activity for [ 3 H]CMP-sia/ CMP was nonetheless abolished (Fig. 2c,e,g ). Given its conserved positioning ( Supplementary Fig. 5c -e), we propose that the TM4-embedded lysine might have a more structural role. More specifically, the lysine might help to stabilize the occluded conformation; indeed, the extracellular half of TM3−TM4, where the lysine is positioned, is thought to move inward during transport 23, 33, 34 . The rearrangement of the TM3−TM4 helices was additionally apparent in CST ZM upon superimposition of the outward CST ZM and occluded TPT structures or in an overlay of the symmetry-related structurally inverted repeats ( Fig. 3a and Supplementary Fig. 2f ). Given the importance of TM3 to complement binding assays, alanine substitutions of Tyr98, Asn102 and Ser95 in hCST were further assessed for transport competence (Fig. 2b-e,g ). Transport measurements were consistent with binding analysis (Fig. 2g) , including the S95A mutant, which showed significantly higher [ 3 H]CMP-sia/CMP exchange activity than the wild type ( Fig. 2g and Supplementary  Fig. 4b,c) . Interestingly, the closely related SLC35A4-5 members naturally harbor an alanine in this position (Supplementary Note). In CST ZM the Ser79 residue (Ser95 in hCST) is positioned deep within the unique CMP binding pocket (Figs. 1e and 2a and Supplementary Fig. 5a,b) . It is plausible that the increase in CMP affinity and transport is caused by the serine-to-alanine mutant making the binding pocket slightly more hydrophobic, or perhaps a structural water being able to replace the lost hydroxyl group to enhance CMP coordination ( Supplementary Fig. 5a,b) . Though unclear, results from our biochemical analysis nonetheless support the physiological position of the CMP binding site.
Dimerization and structural impact of human CST disease mutations. CST ZM homodimerizes in both crystal forms through extensive interactions between equivalent TM5 and TM10 helices, burying a total surface area of ~3.060 Å 2 (Fig. 3b) . CST ZM appears to form two distinct domains, a dimerization domain and a transport domain. The transport domain bundles are held together on the cytoplasmic side through extensive polar interactions (Supplementary Fig. 6 ). It is likely that the dimerization domain acts as a scaffold to support the transport domain bundle rearrangements, which should be similar to that described previously for Vrg4 (ref. 23 ) and structural homologs TPT 33, 34 and YddG
32
. CSTs are associated with congenital disorders of glycosylation type 2f (CDG2f), which result in severe inherited diseases caused by under-sialyation of glycoproteins 18, 35, 36 . More specifically, heterozygous mutations T156R and E196K in CST have been shown to reduce CMP-sialic acid transport into Golgi 18 . In a model of hCST based on CST ZM , Thr156 is located at the dimer interface, and Glu196 (Glu181 in CST ZM ) is located at the cytoplasmic intracellular ionic network (Fig. 3c and Supplementary   Fig. 6 ). Using the GFP-TS assay, we observed that the melting temperature (T m ) of the T156R mutant (26.5 ± 0.5 °C) was significantly lower than that measured for the WT (33.0 ± 0.3 °C), indicating that a potential loss in dimerization impacted stability; in contrast with this finding, all other constructs had a T m within 4 °C from that of the WT (Supplementary Table 1 ). Both T156R and E196K mutations retained levels of binding of CMP and CMP-sialic acid close to those of the WT (Fig. 3d) . However, CMP-sialic acid transport by hCST was severely reduced for the T156R mutant and abolished altogether for E196K (Fig. 3d) . Thus, findings from analysis of the disease mutations support the physiological importance of CST dimerization and the intracellular ionic network.
A chaperone-mediated nucleotide substrate selectivity mechanism. We were unable to detect the binding of sialic acid to either CST ZM or hCST proteins (Fig. 2d,e and Supplementary Fig. 1d ). Although the positively charged surface for sialic acid seems highly favorable, it has been reported that 'free' sialic acid does not compete for the transport of CMP-sialic acid 37 . The inability of free sialic acid to compete on its own during transport rules out the notion that the CMP is required to stabilize the cavity for sialic acid to bind. Our interpretation is that the free sialic acid is unable to reach the binding pocket. In agreement with this line of reasoning, the sialic acid binding pocket is situated at the bottom of a deep cavity, requiring passage through a large area of nonpolar and negatively charged surfaces, which are highly conserved and conspicuously absent of crystallographic waters ( Fig. 1c and Supplementary Fig. 3c ). In proteins that transport free sialic acid, waters hydrated the entire cavity 38 . In support of a physical barrier for the passage of free sialic acid, the apparent binding affinities (K d ) for CMP-sialic acid (K d = 1.5−3.1 mM) were measured to be ~35-fold weaker than for CMP (K d = 32−40 μM) ( Supplementary Fig. 4b,d) . Consistently, the maximum half inhibitory IC 50 values for CMP were ~10-to 25-fold lower than those for CMP-sialic acid (Fig. 2f) .
It has been shown that the closely related SLC35A2 UDPgalactose transporter (Supplementary Note) could be converted into a CST when their respective TM7 segments were swapped, with further enhancement in activity if TM2 and TM3 were also exchanged 39 . Consistently, the CMP binding site in the CST ZM structure is made up of residues located on TM2, TM3 and TM7 (Fig. 2a) . Because the sugar site is located on the other side of the cavity from the nucleotide, the sugar binding site residues are unlikely to have been altered in these chimera mutants. However, the finding that the chimera transported CMP-sialic acid as effectively as hCST implies that sugar recognition probably does not require strict coordination and must be flexible. Indeed, whereas most mammals transport two types of sialic acid into Golgi, N-acetyl-neuraminic acid (Neu5Ac) or N-glycolyl-neuraminic acid (Neu5Gc), humans cannot synthesize Neu5Gc and transport only Neu5Ac 1, 2, 40 . Nonetheless, there are only a couple of conservative amino acid differences between hCST and the closest homologs that transport both, thus showing no obvious adaption to their different substrate requirements. Furthermore, whereas CST ZM can bind and transport CMP-Neu5Ac in exchange for CMP, the mechanism of Neu5Ac glycosylation in plants is unclear 41, 42 . The most likely physiological substrate in plants is CMP-Kdo, which, although considered an extended member of the sialic acid family 27 , is a keto-acidic sugar more similar to Kdn than to Neu5Ac 26, 43 ( Supplementary Fig. 5f ). In agreement with the conclusion that sugar coordination is less stringent than nucleotide recognition, some NST members are further capable of transporting different sugars when coupled to the same nucleotide diphosphate 44, 45 .
Human CST and CST ZM can carry out uniporter and antiporter activity. It is well established that NSTs function as antiporters, exchanging the cytosolic nucleotide sugar for their corresponding nucleotide monophosphate 8, 36 . Most antiporters work by simple competition mechanism between structurally similar yet distinct solute molecules 46 . This finding poses a conceptual problem in NSTs; while the bipartite molecule is matched with a bipartite substrate binding site, the counter substrate is only a competitor for half of the transported solute. This 'flaw' is most exaggerated in CSTs, because CMP is transported in both directions, with substrate recognition governed primarily by the nucleotide monophosphate. Intriguingly, transport measurements in isolated Golgi vesicles and proteoliposomes concluded that CST activities were 'leaky' , because CMP-sialic acid uptake was observed in the absence of vesicles preloaded with CMP 8, 17, 31 . Although compelling, high levels of CMPsialic acid uptake into empty vesicles has made it difficult to come to any firm conclusions regarding coupling. To investigate this observation more thoroughly, we used our proteoliposome transport assay that was extensively optimized using brain lipids to have low background activity in either empty or inactive-mutant-containing liposomes (Figs. 2g and 4a ). As shown in Fig. 4a, robust 17 (Fig. 4b) . Remarkably, we found that the level of [ 3 H]CMP (uptake) was also measurable in the absence of an outwardly directed CMP-sialic acid gradient, consistent with a facilitator primarily recognizing the CMP moiety ( Supplementary Fig. 4e,f) .
Discussion
In summary, CST ZM (i) shares 80-92% sequence identity to plant proteins shown to complement CMP-Neu5Ac transport in deficient CST mammalian cell lines 26, 27 ; (ii) binds CMP-Neu5Ac with the same affinity (K d ) as hCST; (iii) shows enhanced transport of [ 3 H]CMP in the presence of CMP-Neu5Ac; (iv) has an IC 50 for CMP-Neu5Ac equivalent to that of hCST; (v) shows a similar binding mode to that of hCST, as assessed via alanine point mutations; and (vii) binds CMP in a location that is entirely consistent with the 'minimal substrate binding site' pinpointed for hCST by converting a human UDP-galactose transporter into a CST 39, 47 . We have thus shown that CST ZM is a good model system for establishing the molecular basis for sialic acid transport and conclude that molecular recognition for CMP-sialic acid is established primarily through recognition of nucleotide monophosphate CMP.
It was previously shown that the UDP-galactose transporter−CST chimera was able to transport both UDP-galactose and CMP-sialic acid 39, 47 . Because different helices were found to be critical for retaining CMP-sialic acid versus UDP-galactose transport, it was further 23, 58, 59 . Side chains of S79, Y82, N86 and K108 involved in CMP-sialic acid binding are shown as sticks (colored as in Fig. 1d) . b, Cartoon representation of the CST ZM homodimer, which is identical in both crystal forms (for clarity, only the dimer structure grown from LCP crystals is shown). In each protomer, dimerization is mediated by TM5 (cyan) and TM10 (light brown), which are connected via flexible loops to the transport bundles made up of TM3, TM4, TM6 and TM7 (cyan) and TM1, TM2, TM8 and TM9 (wheat). During structural transition from the outward to the occluded conformation, the extracellular half of TM3 and TM4 move inward (from P78 to G113) to gate substrate binding, as apparent from the asymmetry of these regions in a superimposition of the inverted-topology repeats (Fig. 3a) , which is consistent with what was previously described for other drug-metabolite superfamily (DMT) members 23, [32] [33] [34] . In contrast to other dimeric DMT structures 23, 33 , homodimerization of CST ZM is more extensive and not mediated by any lipids. c, Cartoon representation of a modeled hCST protein (Methods) depicting the location of mutations responsible for congenital disorders of glycosylation type 2f. d, CMP-sialic acid binding to hCST using hCST-GFP fusions as determined by a shift in ΔTm after addition of either 1 mM CMP (black bars) or 10 mM CMP-sialic acid (dot-filled brown bars) for WT, T156R and E196K mutants. concluded that the binding sites were located seperately 39, 47 . Thus, the different substrate binding modes observed in the CST and Vrg4 structures are entirely consistent with these biochemical observations. Nonetheless, given that CMP binds at a location in TM3 that is predicted to move inward during occlusion (Fig. 3a) , we cannot exclude the possibility that CMP and CMP-sialic acid could adopt a more central binding mode during transport, perhaps replacing the observed water network. At a structural level, it seems that NST proteins could be adopting unique cavities to match their different substrate binding requirements, which would also explain why there is such a high degree of structural difference between CST ZM and Vrg4. Whereas cavity matching is a common practice in G-proteincoupled receptors 48 , this level of structural divergence is unusual in secondary transporters, which predominantly evolve the side chain chemistry to bind different substrates 46 . This specialization could be to ensure that CMP-sialic acid is not inadvertently transported into the ER by the other nucleotide-sugar transporters and would further explain why CMP is exclusively conjugated to sialic acid.
The concentration of CMP-sialic acid in the cytoplasm (450 μM) is reported to be significantly higher than that of CMP (8 μM) 49 , which is consistent with the lower affinities measured here for CMP-sialic acid versus CMP by CST proteins. The rapid hydrolysis of CMP-sialic acid to CMP in the Golgi would further ensure that the influx of CMP-sialic acid into Golgi is continuously exchanged for CMP efflux, consistent with the physiological annotation of CST as an antiporter 8, 10, 23, 50 . Nevertheless, supporting previous measurements in Golgi vesicles 8, 31 , CST proteins are uniquely capable of facilitative transport (uniport) (Fig. 4c) . After substrate release, uniporters are able to spontaneously reset themselves back to an opposite-facing conformation, whereas antiporters are unable to reset themselves until a counter substrate has bound 46 . This distinction implies that the energetic barriers separating the alternating conformations in CST proteins are lower than those in other NSTs, which, like Vrg4, are thought to be strict antiporters, binding their exchanged substrates with equal affinities 23 . It is plausible that there has been no evolutionary pressure for the Golgi-specific CST antiporter to be strictly coupled, because Golgi membranes are highly leaky and have no membrane potential 51 . While it is possible that the facilitative CST activity has no physiological function, we speculate that uncoupled CMP efflux might be relevant under some circumstances, because low levels of CMP (K i = 40 μM) is a potent inhibitor of sialyltransferase activity in the Golgi 52, 53 . Indeed, for an unknown reason, CMP-sialic acid is synthesized in the nucleus, whereas all other nucleotide sugars are synthesized in the cytoplasm 8, 54 . The compartmentalization of CMP-sialic acid synthesis in the nucleus would indeed suggest that CMP-sialic acid levels are changeable in the cytoplasm, which could make the requirement for uncoupled CMP efflux necessary. Clearly, further investigation will be required to solidify the physiological significance of the CMP-sialic acid uniport activity and to refine the different binding modes possible for this diverse SLC35 transporter family. Nonetheless, the structure of CST ZM and comparative analysis with hCST provide a template for glycopathway engineering and a molecular explanation for their substrate recognition and ; n = 3 independent experiments. c, CST transporters operate by a rocking-switch alternating-access mechanism as they exchange CMP-sialic acid for CMP across the Golgi membrane using an antiport mechanism 46 . However, because the recognition for CMP-sialic acid is established primarily by CMP, they can also carry out facilitative transport of CMP, which means they can operate both as passive and as active antiporters; leak pathways in secondary transporters could serve important biological functions 60 .
Methods
Target identification using fluorescence-based screening methods. CST homologs were synthesized as gene strings (Life Technologies), cloned into the GAL1-inducible TEV-cleavable GFP-His 8 2-μ vector pDDGFP2, transformed into the Saccharomyces cerevisiae strain FGY217 (MATα, ura3-52, lys2Δ201, and pep4Δ) 61 and overexpressed as previously described 28, 62 . In brief, 10 mL S. cerevisiae FGY217 cell cultures in -URA media and 0.1% (v/v) glucose was grown at 30 °C, and expression was induced by the addition of final 2% (v/v) D-galactose at an OD 600 of 0.6. After ~22 h, cells were harvested, resuspended in 1× PBS buffer, and overexpression levels were assessed by whole-cell GFP fluorescence 28, 62 . Fusions with detectable expression levels were regrown in larger 2-L culture volumes, and membranes were subsequently isolated. The monodispersity of expressed fusions were screened using fluorescence-detection size-exclusion chromatography (FSEC) 29 as described previously 62 . Out of the CST homologs screened, CST from Zea mays (CST ZM: uniProt accession number B4FZ94) was the most stable after purification in detergent 63 . To facilitate crystallization of CST ZM , five non-conserved loop residues were mutated using overlap PCR based on a close homolog from Fragaria vesca, which was predicted to be less disordered: H58R, S59T, S61P, P62S and P63V. C-terminal residues retained after TEV cleavage are shown in italic. Large-scale production and purification of CST ZM and hCST. Cells were harvested from 12-L S. cerevisiae cultures, resuspended in buffer containing 50 mM Tris-HCl, pH 7.6, 1 mM EDTA, 0.6 M sorbitol and lysed via mechanical disruption, as described previously 28 . Membranes were isolated via ultracentrifugation at 195,000g for 2 h, homogenized in 20 mM Tris-HCl, pH 7.5, 0.3 M sucrose, 0.1 mM CaCl 2 , flash frozen in liquid nitrogen and stored at −80 °C. Membranes were resuspended in 200 mL of equilibration buffer consisting of 1× PBS, 150 mM NaCl, 10 % (v/v) glycerol. Membranes were solubilized with 2% (w/v) DDM for 1 h at 4 °C. Protein was purified in DDM as described previously 28 . In brief, after ultracentrifugation at 195,000g for 45 min, the supernatant (~200 mL) was supplemented with 10 mM imidazole, pH 7.5, and incubated with 10 mL of Ni 2+ -NTA resin for 2 h at 4 °C. The resin was washed with 200 mL of equilibration buffer supplemented with 30 mM imidazole, pH 7.5, and 0.1% (w/v) DDM, and the protein was eluted using 20 mL of equilibration buffer containing 250 mM imidazole, pH 7.5, and 0.1 % (w/v) DDM. Equimolar TEV-His 6 protease was added to the elution and dialyzed overnight in 3 L of buffer containing 10 mM Tris-HCl, pH 7.5, 150 mM NaCl, and 0.03 % (w/v) DDM. After proteolytic removal of GFPHis 8 by TEV-His 6 protease, the material was loaded onto a 5-mL HisTrap column (no imidazole), and the flow through was collected. The untagged CST ZM or hCST proteins were further purified using size-exclusion chromatography (SEC) in buffer containing 20 mM Tris-HCl, pH 7.5, 150 mM NaCl and 0.03 % (w/v) DDM and then concentrated to ~3 mg•mL -1 for functional experiments.
Transport activity of reconstituted hCST and CST ZM . Total bovine brain lipid extract and cholesteryl-hemisuccinate were mixed in buffer containing 10 mM Tris-HCl, pH 7.5, and 2 mM MgSO 4 to reach a final concentration of 30 and 6 mg•mL -1 , respectively. Either non-deuterated CMP at 0.5 mM or non-deuterated CMP-sialic acid at a final concentration of 1.5 mM was added prior to forming liposomes by multiple rounds of freeze-thaw cycles by flash freezing in liquid nitrogen and thawing at room temperature and sonication. To make proteoliposomes, 10 μg of purified hCST or CST ZM was added into 500 μL of unilamellar vesicles, flash frozen and then thawed at room temperature. Large, unilamellar proteoliposomes were prepared by extrusion through a filter with a membrane pore size of 400 nm. For removal of excess cold substrate, proteoliposomes were pelleted by ultracentrifugation at 150,000g for 1 h, the supernatant was removed, and the pellet was resuspended in Tris-MgSO 4 buffer, pH 7.5, to a final lipid concentration of 80 mg•mL 3 H] CMP-sialic acid (American Radiolabeled Chemicals, Inc). The reaction was stopped by adding of 1 mL of Tris-MgSO 4 buffer, filtering, and further washing with 6 mL of the same buffer. Nonspecific uptake was estimated from empty or non-substrate-binding mutant containing liposomes. The radioactivity corresponding to the internalized substrate was measured using scintillation counting. Each experiment was performed in triplicate.
Determination of the Michaelis constant (K m ) for [ 3 H]CMP/CMP-sia exchange for CST ZM and hCST. CMP uptake by CST ZM and hCST were measured as described for the time course at 90 s. Stochiometric amounts of [ 3 H]CMP (American Radiolabeled Chemicals, Inc) were adjusted with non-radiolabeled CMP at increasing concentrations in the assay buffer. Proteoliposomes were preloaded with steady-state levels of cold CMP-sia at 0.5 mM. Kinetic curves were fitted by nonlinear regression, using data from three independent experiments (the values reported are the mean ± s.e.m. of the fit).
Substrate specificity and binding analysis using GFP-TS. The GFP-TS method, which is derived from the FSEC-TS assay 64 , was used to screen for ligand binding, as described previously 30 . In brief, membranes harboring either hCST or CST ZM (wild-type sequence) were diluted to a final concentration of 3.5 mg•ml −1 in 30 mL of buffer containing 150 mM NaCl, 20 mM Tris-HCl, pH 7.5, and 1 % DDM. After 1 h of solubilization in DDM at 4 °C, the detergent-solubilized membranes were divided into 4-mL aliquots. The compounds CMP, UMP, TMP and GMP dissolved in pure water were separately added to each of the 4-mL aliquots to reach a final concentration of 1 mM. The compounds sialic acid (pH adjusted to 7.5) and CMPsialic acid were freshly prepared in pure water and added to the remaining aliquots to reach a final concentration of 10 mM. After the addition of the final 1% (w/v) β-octyl-D-glucoside (OG), 120-μL fractions were aliquoted into PCR tubes. The PCR tubes were heated at individual temperatures ranging from 4 to 100 °C for 10 min, and aggregated material was sedimented by centrifugation at 5,000g for 30 min at 4 °C using a Microfuge 18 Centrifuge, Beckman Coulter. The resulting supernatants were transferred into a 96-well black clear-bottom plate (Nunc), and the GFP fluorescence (excitation/emission wavelengths: 488 nm/512 nm) intensity was measured using a SpectraMax Gemini EM microplate reader (Molecular Devices). For control samples, pure water was added instead of compounds and were treated in the same way. Each experiment was carried out in triplicate. The hCST and CST ZM melting curves (T m ) were fitted by nonlinear regression using the software Prism. The ΔT m was calculated by subtracting the apparent T m in the presence and absence (control) of the aforementioned compounds.
For binding affinity measurements by GFP-TS, solubilized membrane (hCST or CST ZM ) fusions were prepared as described for the substrate specificity and binding analysis and investigated at ten different final concentrations of CMP-sialic acid ranging from 0 to 50 mM. The prepared protein samples were incubated for 10 min at 5 °C above their respective apparent melting temperatures and subjected to centrifugation at 5,000g for 30 min at 4 °C using a Microfuge 18 Centrifuge, (Beckman Coulter). The K d values were calculated from the data points of the ten different CMP-sialic acid concentrations, fitted by nonlinear regression (one site, total binding), and the values reported are the averaged mean ± s.e.m. of the fit from n = 3 independent titrations.
CMP binding affinities to detergent-solubilized hCST or CST ZM GFP fusioncontaining membranes were previously assessed using the GFP-TS assay 30 . To verify that these CMP binding affinities were comparable to those measured with purified hCST or CST ZM GFP fusions, the experiment was performed as described for CMP-sialic acid, except CMP was added to final concentrations of 0 to 2 mM, and the protein concentration was adjusted to 5,000 RFU (0.04 μg•μl −1 ) in 20 mM Tris-HCl, pH 7.5, 150 mM NaCl and 0.03 % (w/v) DDM.
Analysis of the substrate binding site. All CST mutants were synthesized as gene strings (Life Technologies) and were subcloned and overexpressed, and membranes were isolated as described in the 'Large-scale production and purification of CST ZM and hCST' section. All hCST and CST ZM mutants showed a monodisperse peak in DDM by FSEC 29 and were assessed for their ability to bind CMP or CMP-sialic acid using the GFP-TS assay. The apparent T m was determined in the absence and presence of compounds (CMP, UMP, CMP-sialic acid and sialic acid), as described for the substrate specificity measurements. All melting curves were fitted by nonlinear regression using the software Prism. Each experiment was carried out in triplicate. The ΔT m was calculated by subtracting the absolute difference in the melting temperatures (T m ) in the presence and absence of listed compounds. Because the binding affinities measured by the GFP-TS method were equivalent to binding affinities estimated by ITC 30 , the ΔT m values were considered a robust estimate of substrate binding efficiency. S95A, Y98A, K124A and N102A mutants of hCST were purified as described for hCST wild type and concentrated to ~3 mg•ml −1 for functional experiments.
Crystallization of CST ZM . CST ZM was recloned into a modified S. cerevisiae pDDGFP-2 vector harboring an TEV-cleavable C-terminal GFP-His 8 -Strep tag . DDM-solubilized membranes were prepared from 12 L of S. cerevisiae cells, as outlined in the 'Large-scale production and purification of CST ZM and hCST' section. Solubilizate was incubated with 5 mL of Strep-TactinXT resin (Cat. 2-4010-025; IBA GmbH, Germany) for 2 h at 4 °C. The slurry was transferred into a 100-mL Econo column and washed with 100 mL of buffer containing 1× PBS, 150 mM NaCl, 10 % (v/v) glycerol, and 0.45% (w/v) nonyl-β-D-maltopyranoside (NM). The Strep-Tactin resin containing immobilized CST ZM -GFP-His 8 -Strep tag fusion protein was transferred into a 50-mL Falcon tube, and 5 mg of recombinant His 6 -tagged TEV protease was added and incubated overnight at 4 °C under gentle shaking for proteolytic digestion. The affinity resin was sedimented by centrifugation, and the resulting supernatant containing the untagged CST ZM protein and His-tagged TEV protease was passed through a 5-mL HisTrap column (GE Healthcare) preequilibrated with buffer composed of 20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.45% (w/v) NM. The flow through was collected and concentrated (100 MWCO).
The protein was subjected to SEC using a Superdex 200 column (GE Healthcare) in buffer containing 20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.45 % (w/v) NM.
